Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC9A1 | P19634 | 8/20 | 0.59 |
| ▸ | GRM2 | Q14416 | 2/20 | 0.56 |
| ▸ | KCNMA1 | Q12791 | 1/20 | 0.54 |
| ▸ | EGLN3 | Q9H6Z9 | 1/20 | 0.54 |
| ▸ | RAB9A | P51151 | 2/20 | 0.53 |
| ▸ | NPC1 | O15118 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 1/20 | 0.53 |
| ▸ | MGAM | O43451 | 1/20 | 0.53 |
| ▸ | AMY1A | P0DUB6 | 1/20 | 0.53 |
| ▸ | GAA | P10253 | 1/20 | 0.53 |
| ▸ | SI | P14410 | 1/20 | 0.53 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.51 |
| ▸ | GLA | P06280 | 1/20 | 0.51 |
| ▸ | TSHR | P16473 | 1/20 | 0.51 |
| ▸ | RPS6KA3 | P51812 | 1/20 | 0.51 |
| ▸ | POLB | P06746 | 2/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | ATM | Q13315 | 1/20 | 0.50 |
| ▸ | APAF1 | O14727 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8631037 | 0.89 | SLC9A1 (0.59) | SLC9A1GRM2KCNMA1EGLN3RAB9A | |
| SCHEMBL31483490 | 0.85 | SLC9A1 (0.63) | SLC9A1GRM2KCNMA1EGLN3RAB9A | |
| SCHEMBL31483489 | 0.83 | SLC9A1 (0.61) | SLC9A1GRM2KCNMA1EGLN3RAB9A | |
| SCHEMBL20713929 | 0.82 | SLC9A1 (0.56) | SLC9A1GRM2KCNMA1EGLN3RAB9A | |
| SCHEMBL283984 | 0.81 | SLC9A1 (0.65) | SLC9A1GRM2KCNMA1EGLN3RAB9A | |
| SCHEMBL11536425 | 0.80 | SLC9A1 (0.53) | SLC9A1GRM2KCNMA1EGLN3RAB9A | |
| SCHEMBL513591 | 0.80 | SLC9A1 (0.53) | SLC9A1GRM2KCNMA1EGLN3RAB9A | |
| SCHEMBL29765594 | 0.80 | SLC9A1 (0.53) | SLC9A1GRM2KCNMA1EGLN3RAB9A | |
| SCHEMBL284672 | 0.79 | SLC9A1 (0.66) | SLC9A1GRM2KCNMA1EGLN3RAB9A | |
| SCHEMBL7933277 | 0.79 | SLC9A1 (0.57) | SLC9A1GRM2EGLN3RAB9ANPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5441563-A | Antifoam agents in printing inks | ARMSTRONG WORLD INDUSTRIES, INC. (US) | 1995-08-15 | — | — | US | claimed |
| US-12545750-B2 | Method for the diimide hydrogenation of emulsified unsaturated polymers | PARKER DANE K (US) | 2026-02-10 | — | — | US | disclosed |
| US-20240084046-A1 | METHOD FOR THE DIIMIDE HYDROGENATION OF EMULSIFIED UNSATURATED POLYMERS | ROCKHILL, ALVIN T. | 2024-03-14 | — | — | US | disclosed |
| US-11827723-B1 | Method for the diimide hydrogenation of emulsified unsaturated polymers | ROCKHILL, ALVIN T. | 2023-11-28 | — | — | US | disclosed |
| US-7767751-B2 | Process for preventing gel formation in lattices of hydrogenated, low molecular weight, functionalized elastomers | ZEON CHEMICALS, L.P. (US) | 2010-08-03 | — | — | US | disclosed |
| US-20080275174-A1 | PROCESS FOR PREVENTING GEL FORMATION IN LATTICES OF HYDROGENATED, LOW MOLECULAR WEIGHT, FUNCTIONALIZED ELASTOMERS | ZEON CHEMICALS, L.P. (US) | 2008-11-06 | — | — | US | disclosed |
| US-7411015-B2 | Process for preventing gel formation in lattices of hydrogenated, low molecular weight, functionalized elastomers | ZEON CHEMICALS, L.P. (US) | 2008-08-12 | — | — | US | disclosed |
| US-20070010605-A1 | Process for preventing gel formation in lattices of hydrogenated, low molecular weight, functionalized elastomers | ZEON CHEMICALS, L.P. | 2007-01-11 | — | — | US | disclosed |
| US-5441563-A | Antifoam agents in printing inks | ARMSTRONG WORLD INDUSTRIES, INC. (US) | 1995-08-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12545750-B2 | Method for the diimide hydrogenation of emulsified unsaturated polymers | ALOX15, SOD1, ALOX12 | SLC9A1 1902/4885GRM2 3952/4885KCNMA1 4603/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.